These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17562541

  • 21. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
    Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Baradaran N, Mehrsai AR, Pourmand G.
    Prostate; 2009 Dec 01; 69(16):1744-50. PubMed ID: 19676082
    [Abstract] [Full Text] [Related]

  • 22. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
    Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM.
    Cancer Causes Control; 2016 Feb 01; 27(2):175-82. PubMed ID: 26589415
    [Abstract] [Full Text] [Related]

  • 23. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 01; 17(2):286-91. PubMed ID: 18268111
    [Abstract] [Full Text] [Related]

  • 24. Plasma androgen concentrations and risk of incident ovarian cancer.
    Tworoger SS, Lee IM, Buring JE, Hankinson SE.
    Am J Epidemiol; 2008 Jan 15; 167(2):211-8. PubMed ID: 17982156
    [Abstract] [Full Text] [Related]

  • 25. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men.
    Allen NE, Appleby PN, Davey GK, Key TJ.
    Br J Cancer; 2000 Jul 15; 83(1):95-7. PubMed ID: 10883675
    [Abstract] [Full Text] [Related]

  • 26. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
    Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL.
    Cancer Res; 1990 Jan 01; 50(1):169-73. PubMed ID: 2293551
    [Abstract] [Full Text] [Related]

  • 27. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
    Sher DJ, Mantzoros C, Jacobus S, Regan MM, Lee GS, Oh WK.
    Urology; 2009 Feb 01; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
    [Abstract] [Full Text] [Related]

  • 28. Serum and urinary androgens and risk of breast cancer in postmenopausal women.
    Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S.
    Cancer Res; 1991 May 15; 51(10):2572-6. PubMed ID: 2021938
    [Abstract] [Full Text] [Related]

  • 29. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
    Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S.
    J Clin Oncol; 2008 Dec 20; 26(36):5923-9. PubMed ID: 19018085
    [Abstract] [Full Text] [Related]

  • 30. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
    Faydaci G, Bilal E, Necmettin P, Fatih T, Asuman O, Uğur K.
    Aging Male; 2008 Dec 20; 11(4):189-92. PubMed ID: 19172550
    [Abstract] [Full Text] [Related]

  • 31. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 32. Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.
    Dorgan JF, Albanes D, Virtamo J, Heinonen OP, Chandler DW, Galmarini M, McShane LM, Barrett MJ, Tangrea J, Taylor PR.
    Cancer Epidemiol Biomarkers Prev; 1998 Dec 15; 7(12):1069-74. PubMed ID: 9865423
    [Abstract] [Full Text] [Related]

  • 33. Hypogonadism in male patients with cancer.
    Garcia JM, Li H, Mann D, Epner D, Hayes TG, Marcelli M, Cunningham GR.
    Cancer; 2006 Jun 15; 106(12):2583-91. PubMed ID: 16688773
    [Abstract] [Full Text] [Related]

  • 34. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
    Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J.
    Cancer Epidemiol Biomarkers Prev; 2007 Jul 15; 16(7):1364-70. PubMed ID: 17585059
    [Abstract] [Full Text] [Related]

  • 35. 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.
    Guess HA, Friedman GD, Sadler MC, Stanczyk FZ, Vogelman JH, Imperato-McGinley J, Lobo RA, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 1997 Jan 15; 6(1):21-4. PubMed ID: 8993793
    [Abstract] [Full Text] [Related]

  • 36. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S, Egevad L, Gann PH, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Sieri S, Vineis P, Palli D, Quirós JR, Ardanaz E, Chirlaque MD, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Bikou C, Trichopoulos D, Stattin P, Jenab M, Ferrari P, Slimani N, Riboli E, Kaaks R.
    Int J Cancer; 2007 Sep 15; 121(6):1331-8. PubMed ID: 17514649
    [Abstract] [Full Text] [Related]

  • 37. Preoperative serum sex hormone-binding globulin as a predictive marker for extraprostatic extension of tumor in patients with clinically localized prostate cancer.
    Lee SE, Chung JS, Han BK, Park CS, Moon KH, Byun SS, Choe G, Hong SK.
    Eur Urol; 2008 Dec 15; 54(6):1324-32. PubMed ID: 18339472
    [Abstract] [Full Text] [Related]

  • 38. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, Dobs A, Basaria S, Golden SH, Platz EA.
    Diabetes Care; 2007 Feb 15; 30(2):234-8. PubMed ID: 17259487
    [Abstract] [Full Text] [Related]

  • 39. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.
    Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA.
    Urology; 2008 Dec 15; 72(6):1240-5. PubMed ID: 18692874
    [Abstract] [Full Text] [Related]

  • 40. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.
    Sawada N, Iwasaki M, Inoue M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S, Japan Public Health Center-based Prospective Study Group.
    Cancer Sci; 2010 Dec 15; 101(12):2652-7. PubMed ID: 20942896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.